tiprankstipranks
Advertisement
Advertisement

DTIL Stock Latest News

Precision BioSciences Advances Gene-Editing Programs in Hepatitis B
Company AnnouncementsPrecision BioSciences Advances Gene-Editing Programs in Hepatitis B
15h ago
8K
DTIL
Precision BioSciences announces addition to the Russell 2000 Index
PremiumThe Fly
Precision BioSciences announces addition to the Russell 2000 Index
3d ago
DTIL
Precision BioSciences Extends Term Loan Maturity to 2029
PremiumCompany Announcements
Precision BioSciences Extends Term Loan Maturity to 2029
15d ago
8K
DTIL
Precision BioSciences initiated with an Outperform at Oppenheimer
PremiumThe Fly
Precision BioSciences initiated with an Outperform at Oppenheimer
23d ago
DTIL
Patrick Trucchio Reiterates Buy on Precision BioSciences with Unchanged $60 Price Target on Promising ELIMINATE-B Data and ARCUS-Based Upside
PremiumRatings
Patrick Trucchio Reiterates Buy on Precision BioSciences with Unchanged $60 Price Target on Promising ELIMINATE-B Data and ARCUS-Based Upside
1M ago
DTIL
Precision BioSciences Reports Promising New Hepatitis B Trial Data
PremiumCompany AnnouncementsPrecision BioSciences Reports Promising New Hepatitis B Trial Data
1M ago
8K
DTIL
Precision BioSciences presents new data from ELIMINATE-B study at EASL
Premium
The Fly
Precision BioSciences presents new data from ELIMINATE-B study at EASL
1M ago
DTIL
Precision BioSciences Shareholders Approve Incentive Plan and Directors
Premium
Company Announcements
Precision BioSciences Shareholders Approve Incentive Plan and Directors
1M ago
8K
DTIL
Precision BioSciences announces results from low-dose cohort of ECUR-506
PremiumThe Fly
Precision BioSciences announces results from low-dose cohort of ECUR-506
1M ago
DTIL
Precision BioSciences presents new preclinical data on Pbgene-DMD program
PremiumThe Fly
Precision BioSciences presents new preclinical data on Pbgene-DMD program
2M ago
DTIL
Precision BioSciences sees cash runway through 2028
PremiumThe Fly
Precision BioSciences sees cash runway through 2028
2M ago
DTIL
Precision BioSciences reports Q1 EPS (75c) vs. ($2.21) last year
PremiumThe Fly
Precision BioSciences reports Q1 EPS (75c) vs. ($2.21) last year
2M ago
DTIL
Precision BioSciences activates first clinical trial site for PBGENE-DMD
PremiumThe FlyPrecision BioSciences activates first clinical trial site for PBGENE-DMD
2M ago
DTIL
Precision BioSciences announces oral presentation at ASGCT 2026
Premium
The Fly
Precision BioSciences announces oral presentation at ASGCT 2026
2M ago
DTIL
Precision BioSciences announces grant of inducement awards
Premium
The Fly
Precision BioSciences announces grant of inducement awards
2M ago
DTIL
Precision Bio’s 15-Year HBV Follow-Up Study: What Investors Should Know
PremiumCompany Announcements
Precision Bio’s 15-Year HBV Follow-Up Study: What Investors Should Know
2M ago
DTIL
Precision BioSciences assumed with a Buy at JonesResearch
PremiumThe Fly
Precision BioSciences assumed with a Buy at JonesResearch
3M ago
DTIL
Precision BioSciences receives CTA approval to expand Eliminate-B trial
PremiumThe Fly
Precision BioSciences receives CTA approval to expand Eliminate-B trial
3M ago
DTIL
Precision BioSciences Highlights PBGENE-DMD Program and Trial
PremiumCompany Announcements
Precision BioSciences Highlights PBGENE-DMD Program and Trial
4M ago
8K
DTIL
Precision BioSciences Advances PBGENE-DMD Trial, Putting New Focus on Duchenne Gene Therapy
PremiumCompany AnnouncementsPrecision BioSciences Advances PBGENE-DMD Trial, Putting New Focus on Duchenne Gene Therapy
4M ago
DTIL
Precision BioSciences reports Q4 EPS $1.05, consensus (64c)
Premium
The Fly
Precision BioSciences reports Q4 EPS $1.05, consensus (64c)
4M ago
DTIL
Precision receives two notices of allowance from USPTO for PBGENE-HBV
Premium
The Fly
Precision receives two notices of allowance from USPTO for PBGENE-HBV
4M ago
DTIL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >